We are live on ! Find out more
PCM

Parsons Capital Management Portfolio holdings

AUM $2.21B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+12.76%
1 Year Est. Return
+28.12%
3 Year Est. Return
+84.89%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.13%
AUM
$996M
AUM Growth
+$73M
Cap. Flow
-$4.39M
Cap. Flow %
-0.44%
Top 10 Hldgs %
32.34%
Holding
361
New
17
Increased
88
Reduced
159
Closed
12

Sector Composition

Rank Sector Weight
1 Technology 19.34%
2 Healthcare 13.59%
3 Financials 12.59%
4 Industrials 12.28%
5 Consumer Discretionary 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLNX
126
DELISTED
Xilinx Inc
XLNX
$1.69M 0.17%
17,310
-435
-2% -$40.9K
SNY icon
127
Sanofi
SNY
$104B
$1.67M 0.17%
33,334
+1,449
+5% +$67.9K
XYL icon
128
Xylem
XYL
$28.1B
$1.64M 0.17%
20,863
-283
-1% -$22K
FENY icon
129
Fidelity MSCI Energy Index ETF
FENY
$1.94B
$1.58M 0.16%
+98,800
New +$1.55M
IYW icon
130
iShares US Technology ETF
IYW
$25.2B
$1.57M 0.16%
26,932
IGIB icon
131
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$1.55M 0.16%
26,680
+198
+0.7% +$11.5K
IUSG icon
132
iShares Core S&P US Growth ETF
IUSG
$33.7B
$1.52M 0.15%
22,434
+902
+4% +$58.4K
SLB icon
133
SLB Ltd
SLB
$75B
$1.5M 0.15%
37,261
-5,966
-14% -$213K
SPSB icon
134
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.7B
$1.48M 0.15%
47,967
-332
-0.7% -$10.2K
SYK icon
135
Stryker
SYK
$130B
$1.44M 0.14%
6,849
+125
+2% +$25.9K
CLX icon
136
Clorox
CLX
$12.7B
$1.41M 0.14%
9,207
-17
-0.2% -$2.54K
VFC icon
137
VF Corp
VFC
$5.89B
$1.41M 0.14%
14,115
BP icon
138
BP
BP
$107B
$1.4M 0.14%
37,169
-8,574
-19% -$326K
COR icon
139
Cencora
COR
$61.2B
$1.4M 0.14%
16,463
-305
-2% -$26.1K
IGV icon
140
iShares Expanded Tech-Software Sector ETF
IGV
$14.5B
$1.38M 0.14%
29,675
+50
+0.2% +$2.22K
BN icon
141
Brookfield
BN
$108B
$1.38M 0.14%
66,730
+106
+0.2% +$2.11K
FLOT icon
142
iShares Floating Rate Bond ETF
FLOT
$10.3B
$1.36M 0.14%
26,785
-960
-3% -$48.9K
VYM icon
143
Vanguard High Dividend Yield ETF
VYM
$82.8B
$1.36M 0.14%
14,558
-117
-0.8% -$10.6K
BRK.A icon
144
Berkshire Hathaway Class A
BRK.A
$1.12T
$1.36M 0.14%
4
USMV icon
145
iShares MSCI USA Min Vol Factor ETF
USMV
$24.2B
$1.3M 0.13%
19,847
+136
+0.7% +$8.73K
RDS.A
146
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.29M 0.13%
21,949
-4,454
-17% -$260K
ALGN icon
147
Align Technology
ALGN
$12.3B
$1.29M 0.13%
4,617
FLRN icon
148
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.09B
$1.29M 0.13%
41,885
-338
-0.8% -$10.4K
KBWB icon
149
Invesco KBW Bank ETF
KBWB
$6.87B
$1.29M 0.13%
22,100
VV icon
150
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
$1.27M 0.13%
8,624
+30
+0.3% +$4.24K

Similar funds

Parsons Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Parsons Capital Management held 361 positions worth $996M, up 7.9% from $923M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parsons Capital Management's Q4 2019 filing shows 17 new, 88 increased, 159 reduced and 12 closed positions. Its largest new stake was Relmada Therapeutics: 366,933 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $6.06M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Parsons Capital Management's largest Q4 2019 buy was Relmada Therapeutics: 366,933 shares worth $14.3M.
  • Parsons Capital Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.4M increase.
  • Parsons Capital Management's biggest Q4 2019 reduction was 3M, cutting an estimated $6.04M.
  • Parsons Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $6.06M.
  • Parsons Capital Management's ten largest holdings make up 32% of its $996M portfolio in Q4 2019.
  • Parsons Capital Management opened 17 new positions and closed 12 in Q4 2019.
  • Parsons Capital Management's portfolio value rose 7.9% quarter-over-quarter to $996M.

Based on Parsons Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.